SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-03-31 18:11
Tx date 2025-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$34,520
+3,096 vol
$11.15 each 		61,585
Filed 2025-03-31 18:08
Tx date 2025-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-6,192 vol 		58,489
Filed 2025-03-19 08:44
Tx date 2025-03-18 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+5,479 vol 		64,681
Filed 2025-03-11 12:12
Tx date 2024-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$3,281
+370 vol
$8.87 each 		59,202
Filed 2025-03-11 12:10
Tx date 2024-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$24,903
+2,578 vol
$9.66 each 		58,832
Filed 2024-12-16 14:39
Tx date 2024-12-13 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-68,138.40
-5,874 vol
$11.60 each 		56,254
Filed 2024-12-16 14:38
Tx date 2024-12-13 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$56,390
+5,874 vol
$9.60 each 		62,128
Filed 2024-12-16 14:36
Tx date 2024-12-13 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$-56,390.40
-5,874 vol
$9.60 each 		0
Filed 2024-12-12 10:30
Tx date 2024-12-12 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-55,628.75
-4,775 vol
$11.65 each 		56,254
Filed 2024-12-12 10:28
Tx date 2024-12-12 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$39,250
+4,775 vol
$8.22 each 		61,029
Filed 2024-12-12 10:26
Tx date 2024-12-12 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
51 - Exercise of options 		$-39,250.50
-4,775 vol
$8.22 each 		5,874
Filed 2024-03-27 19:20
Tx date 2024-03-27 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights 		$57,689
+6,631 vol
$8.70 each 		56,254
Filed 2024-03-20 09:08
Tx date 2024-03-19 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$31,246
+3,676 vol
$8.50 each 		49,623
Filed 2024-03-20 09:07
Tx date 2024-03-19 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-7,352 vol 		45,947
Filed 2024-03-19 09:40
Tx date 2023-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$3,509
+454 vol
$7.73 each 		53,299
Filed 2024-03-19 09:39
Tx date 2023-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$28,582
+3,688 vol
$7.75 each 		52,845
Filed 2023-03-31 18:40
Tx date 2023-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+7,430 vol 		49,157
Filed 2023-03-31 18:39
Tx date 2023-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$47,047
+6,273 vol
$7.50 each 		41,727
Filed 2023-03-31 18:37
Tx date 2023-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-12,546 vol 		35,454
Filed 2023-03-22 12:25
Tx date 2022-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,016
+143 vol
$7.11 each 		48,000
Filed 2023-03-22 12:23
Tx date 2022-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$24,243
+2,993 vol
$8.10 each 		47,857
Filed 2022-04-01 16:56
Tx date 2022-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights 		$53,603
+5,897 vol
$9.09 each 		44,864
Filed 2022-03-15 18:33
Tx date 2021-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$17,270
+2,240 vol
$7.71 each 		38,967
Filed 2021-03-23 08:50
Tx date 2021-03-19 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights 		$52,005
+7,124 vol
$7.30 each 		36,727
Filed 2021-03-11 14:48
Tx date 2020-12-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$4,607
+950 vol
$4.85 each 		29,603
Filed 2020-04-03 08:45
Tx date 2020-03-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+12,408 vol 		28,653
Filed 2020-03-23 09:39
Tx date 2019-03-19 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$39,250
+4,775 vol
$8.22 each 		10,649
Filed 2020-03-23 09:31
Tx date 2020-03-20 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,925
+2,500 vol
$3.57 each 		16,245
Filed 2019-03-22 15:21
Tx date 2019-03-19 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options 		$39,250
+4,775 vol
$8.22 each
Filed 2020-03-02 10:14
Tx date 2020-01-31 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$11,422
+1,552 vol
$7.36 each 		18,520
Filed 2019-03-28
Tx date 2019-03-28 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$90,021
+11,955 vol
$7.53 each 		16,968
Filed 2019-03-22
Tx date 2019-03-19 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options 		$39,250
+4,775 vol
$8.22 each 		5,013
Filed 2019-03-07
Tx date 2018-09-10 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-07
Tx date 2018-09-10 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		238
Filed 2018-09-13
Tx date 2018-09-10 		$RX
BioSyent Inc. 		March, Robert Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares - Options
00 - Opening Balance-Initial SEDI Report 		5,874